Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatm... SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0521 | 5.67538126362 | 0.918 | 0.98 | 0.8854 | 85886 | 0.91769857 | CS |
| 4 | -0.0699 | -6.72115384615 | 1.04 | 1.04 | 0.728398 | 100708 | 0.896205 | CS |
| 12 | -0.0499 | -4.89215686275 | 1.02 | 1.245 | 0.728398 | 137589 | 1.0136939 | CS |
| 26 | -0.4799 | -33.0965517241 | 1.45 | 1.5 | 0.728398 | 181543 | 1.14770592 | CS |
| 52 | -0.5099 | -34.4527027027 | 1.48 | 3.07 | 0.728398 | 181240 | 1.56056306 | CS |
| 156 | -1.3399 | -58.0043290043 | 2.31 | 3.87 | 0.728398 | 343367 | 2.41258193 | CS |
| 260 | 0.1439 | 17.4170902929 | 0.8262 | 11.3 | 0.6018 | 375652 | 3.78396573 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
